About
Professor Lyndell Lim
Head of Clinical Trials Research
Professor Lyndell Lim is a uveitis and medical retina subspecialist and leads CERA’s clinical trials research.
Professor Lyndell Lim
Head of Clinical Trials Research
MBBS, DMedSci, FRANZCO
Professor Lyndell Lim is Head of the Clinical Trials Research Centre at CERA.
After completing her ophthalmology training in Melbourne, Prof Lim then completed two Fellowships – one in medical retina at the Royal Victorian Eye and Ear Hospital, and one in uveitis/ocular inflammatory disease at the Casey Eye Institute, Portland, Oregon, USA.
Prof Lim’s main research interests are clinical studies in the field of uveitis and ocular immunology, and diabetic retinopathy. Her team runs both investigator-initiated and sponsored clinical trials that aim to investigate new treatments in a variety of ophthalmic diseases.
Key research questions
- Can we find new treatments for non-infectious uveitis that are better tolerated (i.e. fewer side effects) and are more effective than what is currently available?
Current projects
Selected publications
My team
Key collaborators
Funding and support
Current projects
- POINT trial
- MERIT trial
- ADVISE trial
- ADJUST trial
- Filgotinib clinical trials (3)
- DR in pregnancy
- DME trials
Selected publications
Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR; FAST Research Group. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis A Randomized Clinical Trial. JAMA 2019 Sept 10; 322(10):936-945 DOI: 10.1001/jama.2019.12618
Chiu ZK, Lim LL, Rogers SL, Hall AJ. Patterns of Vitamin D Levels and Exposures in Active and Inactive Non-Infectious Uveitis Patients. Ophthalmology 2019 Jul 11 [Epub ahead of print] DOI: 10.1016/j.ophtha.2019.06.030
Lim LL, Silva DG, Lo TC, Pimentel RS, Butzkueven H, Hall AJ. Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod: Incidence, Prevalence and Impact on Disease Course. Ophthalmology 2019 Mar; 126(3):438-444 DOI: 10.1016/j.ophtha.2018.10.013
Kandasamy R, Constantinou M, Rogers SL, Sandhu SS, Wickremasinghe S, Al-Qureshi S, Lim LL. Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results. Br J Ophthalmology 2019 Feb 28
Ma SP, Rogers SL, Hall AJ, Hodgson LAB, Brennan J, Stawell RJ, Lim LL. Sarcoidosis-related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis. Am J Opththal. 2019 Feb 189:30-6 DOI: 10.1016/j.ajo.2018.09.013
See more publications
My team
- Associate Professor Elaine Chong – Senior Research Fellow
- Dr Jonathan Goh – Research Fellow
- Dr Thanh Nguyen – Senior Research Fellow
- Dr Sukhpal Sandhu – Senior Research Fellow
- Associate Professor Sanjeewa Wickremasinghe – Senior Research Fellow
- Larissa Byass – Study Coordinator
- Thuy Chao – Senior Study Coordinator
- Marios Constantinou – Clinical Trials Research Manager
- Angelica de Guzman – Study Coordinator
- Peta Holly – Study Coordinator
- Lin Lin – Study Coordinator
- Kelly Mikunda – Executive Assistant
- Sophie Rogers – Epidemiologist/Statistician
- Lilian Stojimenov – Study Coordinator
- Kiera Young – Study Coordinator
- Michael Dong – BMedSci student
Edmund Kong – BMedSci student
Sachin Phakey – MDRP student
Dr Felicia Widyaputri – PhD Student
Key collaborators
- MUST Group (Doug Jabs, USA)
- FAST Group (Nisha Acharaya, USA)
- Peter McCluskey (Sydney)
- Mark Gillies (Sydney)
- Samantha Fraser-Bell (Sydney)
- Rachael Neiderer (Auckland)
- Jennifer Wilkinson-Berka (UoM)
Funding and support
Thank you to the following organisations for their support:
- NHMRC
- ORIA
- JDRF
- NIH
- Ramaciotti
- Diabetes Australia
- Alfred Fenton Trust
Contact Professor Lyndell Lim
Leave a direct enquiry for CERA below!
Please note: Unfortunately we are not able to provide individual medical advice over email.